Alexion NEPH-202 Ravulizumab trial

Brief description of study

Alexion NEPH-202 Ravulizumab trial

Clinical Study Identifier: s20-01762 Identifier: NCT04564339
Principal Investigator: Howard Belmont.
Other Investigator: Janine M. Sullivan.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.